BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22537680)

  • 1. Synthesis of methoxylated goniothalamin, aza-goniothalamin and γ-pyrones and their in vitro evaluation against human cancer cells.
    Barcelos RC; Pastre JC; Caixeta V; Vendramini-Costa DB; de Carvalho JE; Pilli RA
    Bioorg Med Chem; 2012 Jun; 20(11):3635-51. PubMed ID: 22537680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and in vitro evaluation against human cancer cells of 5-methyl-5-styryl-2,5-dihydrofuran-2-ones, a new series of goniothalamin analogues.
    Bruder M; Vendramini-Costa DB; de Carvalho JE; Pilli RA
    Bioorg Med Chem; 2013 Sep; 21(17):5107-17. PubMed ID: 23876338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic activity of (S)-goniothalamin and analogues against human cancer cells.
    Fátima Ad; Kohn LK; Carvalho JE; Pilli RA
    Bioorg Med Chem; 2006 Feb; 14(3):622-31. PubMed ID: 16202605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (R)-Goniothalamin: total syntheses and cytotoxic activity against cancer cell lines.
    de Fátima A; Kohn LK; Antônio MA; de Carvalho JE; Pilli RA
    Bioorg Med Chem; 2005 Apr; 13(8):2927-33. PubMed ID: 15781402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric total synthesis and antiproliferative activity of goniothalamin oxide isomers.
    Marquissolo C; de Fátima A; Kohn LK; Ruiz AL; de Carvalho JE; Pilli RA
    Bioorg Chem; 2009 Apr; 37(2):52-6. PubMed ID: 19185327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of N-acylated aza-goniothalamin derivatives and evaluation of their in vitro and in vivo antitumor activity.
    Barcelos RC; Pastre JC; Vendramini-Costa DB; Caixeta V; Longato GB; Monteiro PA; de Carvalho JE; Pilli RA
    ChemMedChem; 2014 Dec; 9(12):2725-43. PubMed ID: 25263285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of Nitrogen-Containing Goniothalamin Analogues with Higher Cytotoxic Activity and Selectivity against Cancer Cells.
    Meirelles MA; Braga CB; Ornelas C; Pilli RA
    ChemMedChem; 2019 Aug; 14(15):1403-1417. PubMed ID: 31260170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity of goniothalamin enantiomers in renal cancer cells: involvement of nitric oxide, apoptosis and autophagy.
    de Fátima A; Zambuzzi WF; Modolo LV; Tarsitano CA; Gadelha FR; Hyslop S; de Carvalho JE; Salgado I; Ferreira CV; Pilli RA
    Chem Biol Interact; 2008 Nov; 176(2-3):143-50. PubMed ID: 18771661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of pironetin analogues with simplified structure and study of their interactions with microtubules.
    Marco JA; García-Pla J; Carda M; Murga J; Falomir E; Trigili C; Notararigo S; Díaz JF; Barasoain I
    Eur J Med Chem; 2011 May; 46(5):1630-7. PubMed ID: 21396747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and cytotoxic activity of fluorinated analogues of Goniothalamus lactones. Impact of fluorine on oxidative processes.
    Dumitrescu L; Mai Huong DT; Van Hung N; Crousse B; Bonnet-Delpon D
    Eur J Med Chem; 2010 Jul; 45(7):3213-8. PubMed ID: 20392543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (-)-Tarchonanthuslactone: Design of New Analogues, Evaluation of their Antiproliferative Activity on Cancer Cell Lines, and Preliminary Mechanistic Studies.
    Toneto Novaes LF; Martins Avila C; Pelizzaro-Rocha KJ; Vendramini-Costa DB; Pereira Dias M; Barbosa Trivella DB; Ernesto de Carvalho J; Ferreira-Halder CV; Pilli RA
    ChemMedChem; 2015 Oct; 10(10):1687-99. PubMed ID: 26305900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, in vitro cytotoxicity evaluation and structure-activity relationship of goniothalamin analogs.
    Mohideen M; Zulkepli S; Nik-Salleh NS; Zulkefeli M; Weber JF; Rahman AF
    Arch Pharm Res; 2013 Jul; 36(7):812-31. PubMed ID: 23543632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of 2-iminothiazolidin-4-one moiety-containing compounds as potent antiproliferative agents.
    Zhai X; Li W; Chen D; Lai R; Liu J; Gong P
    Arch Pharm (Weinheim); 2012 May; 345(5):360-7. PubMed ID: 22223396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Goniothalamin induces cell cycle-specific apoptosis by modulating the redox status in MDA-MB-231 cells.
    Chen WY; Wu CC; Lan YH; Chang FR; Teng CM; Wu YC
    Eur J Pharmacol; 2005 Oct; 522(1-3):20-9. PubMed ID: 16202990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative activity of goniothalamin enantiomers involves DNA damage, cell cycle arrest and apoptosis induction in MCF-7 and HB4a cells.
    Semprebon SC; Marques LA; D'Epiro GF; de Camargo EA; da Silva GN; Niwa AM; Macedo Junior F; Mantovani MS
    Toxicol In Vitro; 2015 Dec; 30(1 Pt B):250-63. PubMed ID: 26522230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Bicycloaryl substituted (S)- and (R)-5,6-dihydro-2H-pyran-2-ones: asymmetric synthesis, and anti-proliferative properties.
    Kasaplar P; Yilmazer O; Cağir A
    Bioorg Med Chem; 2009 Jan; 17(1):311-8. PubMed ID: 19022676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanocidal activity of 5,6-dihydropyran-2-ones against free trypomastigotes forms of Trypanosoma cruzi.
    de Fátima A; Marquissolo C; de Albuquerque S; Carraro-Abrahão AA; Pilli RA
    Eur J Med Chem; 2006 Oct; 41(10):1210-3. PubMed ID: 16815596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total synthesis of a potent hybrid of the anticancer natural products dictyostatin and discodermolide.
    Paterson I; Naylor GJ; Wright AE
    Chem Commun (Camb); 2008 Oct; (38):4628-30. PubMed ID: 18815706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total synthesis and biological evaluation of potent analogues of dictyostatin: modification of the C2-C6 dienoate region.
    Paterson I; Gardner NM; Guzmán E; Wright AE
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6268-72. PubMed ID: 18951787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in Vitro cytotoxic activities of 2-alkyl-2,3-dihydro-1H-2,6-diazacyclopenta[b]anthracene-5,10-diones.
    Kwak JH; Namgoong K; Jung JK; Han SB; Cho J; Kim HM; Park SG; Lee K; Kang JS; Lee H
    Arch Pharm Res; 2010 May; 33(5):663-7. PubMed ID: 20512462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.